Document Detail


Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
MedLine Citation:
PMID:  10655195     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: To compare the effect on intraocular pressure (IOP) of latanoprost monotherapy and timolol-pilocarpine in patients with glaucoma or ocular hypertension with inadequately controlled IOP on topical beta adrenergic antagonists. METHODS: This was a multicentre, randomised, observer masked, 6 week study performed in France and Sweden. 23 centres enrolled 237 patients with glaucoma or ocular hypertension and an IOP of at least 22 mm Hg on treatment with topical beta adrenergic antagonists, alone or in combination. After a 21 day run in period on timolol 0.5% twice daily, patients were randomised either to latanoprost 0.005% once daily or to a fixed combination of timolol-pilocarpine twice daily. Changes in mean diurnal IOP from the baseline to the 6 week visit were determined with an analysis of covariance. RESULTS: Mean diurnal IOP was statistically significantly decreased from baseline in both groups (p<0.001). Switching to latanoprost treatment reduced mean diurnal IOP by 5.4 (SEM 0.3) mm Hg (ANCOVA -22%) and switching to timolol-pilocarpine treatment reduced mean diurnal IOP by 4.9 (0.4) mm Hg (-20%). Blurred vision, decreased visual acuity, decreased twilight vision, and headache were statistically significantly more frequent in the timolol-pilocarpine group. CONCLUSIONS: Latanoprost monotherapy was at least as effective as fixed combination timolol-pilocarpine twice daily treatment in reducing mean diurnal IOP in patients not adequately controlled on topical beta adrenergic antagonists. Latanoprost was better tolerated than timolol-pilocarpine regarding side effects. These results indicate that a switch to latanoprost monotherapy can be attempted before combination therapy is initiated.
Authors:
J P Nordmann; M Söderström; J F Rouland; F Malecaze
Related Documents :
2388875 - Transdermal timolol: beta blockade and plasma concentrations after application for 48 h...
12059865 - Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo...
6123335 - Influence of beta adrenergic blockade on effects of physical training in patients with ...
3342165 - Abolition of exercise induced st depression after exercise training and its recurrence ...
8299615 - Pulmonary gas exchange and breathing pattern during and after exercise in highly traine...
11527115 - Safety and efficacy of beta-blockers in the treatment of stable angina pectoris.
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The British journal of ophthalmology     Volume:  84     ISSN:  0007-1161     ISO Abbreviation:  Br J Ophthalmol     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-03-27     Completed Date:  2000-03-27     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0421041     Medline TA:  Br J Ophthalmol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  181-5     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, Hôpital des Quinze-Vingts, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antihypertensive Agents / therapeutic use*
Drug Combinations
Female
Glaucoma / drug therapy*
Humans
Intraocular Pressure / drug effects
Male
Middle Aged
Miotics / therapeutic use*
Ocular Hypertension / drug therapy*
Ophthalmic Solutions
Pilocarpine / therapeutic use*
Prostaglandins F, Synthetic / therapeutic use*
Timolol / therapeutic use*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Drug Combinations; 0/Miotics; 0/Ophthalmic Solutions; 0/Prostaglandins F, Synthetic; 130209-82-4/latanoprost; 26839-75-8/Timolol; 92-13-7/Pilocarpine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vertical or asymmetric nystagmus need not imply neurological disease.
Next Document:  Detection of gonioscopically occludable angles and primary angle closure glaucoma by estimation of l...